The brain-gut-enteric microbiota axis is a bidirectional communication system that influences gut function and health. The enteric microbiota, including both commensal and pathogenic organisms, plays a crucial role in this interaction. The brain can influence the microbiota through changes in gut motility, secretion, and permeability, while the microbiota can affect the brain via signaling molecules. Enterochromaffin cells are key players in this communication, transmitting signals between the gut and the nervous system. Vagal and afferent innervation of these cells facilitates direct signaling to neuronal circuits, influencing pain, immune responses, and homeostasis. Disruptions in this interaction may contribute to gastrointestinal diseases, including inflammatory and functional bowel disorders. Stress and psychological factors can alter the composition and biomass of the enteric microbiota, affecting gut function and immune responses. The autonomic nervous system modulates gut functions such as motility, secretion, and immune responses, while stress-induced changes in gut permeability can allow bacterial antigens to enter the gut epithelium, triggering immune responses. The enteric microbiota can also influence the nervous system through signaling molecules, such as serotonin, which are secreted by enterochromaffin cells and can affect gut motility and secretion. The interaction between the gut microbiota and the nervous system is bidirectional, with the microbiota influencing gut function and the nervous system modulating the microbiota. This communication is mediated through various mechanisms, including direct signaling and paracrine interactions. The enteric microbiota can also influence the brain through signaling molecules, such as serotonin, which are involved in mood regulation and gut function. Stress can alter the balance of the gut microbiota, leading to changes in gut motility and secretion, which can contribute to gastrointestinal disorders. Clinical evidence suggests that modifications to the gut microbiota, such as through probiotics, can improve symptoms in conditions like IBS and IBD. The bidirectional signaling between the gut microbiota, the gut, and the brain has important implications for the treatment of gastrointestinal disorders. Understanding these interactions can lead to new therapeutic strategies for managing chronic intestinal disorders.The brain-gut-enteric microbiota axis is a bidirectional communication system that influences gut function and health. The enteric microbiota, including both commensal and pathogenic organisms, plays a crucial role in this interaction. The brain can influence the microbiota through changes in gut motility, secretion, and permeability, while the microbiota can affect the brain via signaling molecules. Enterochromaffin cells are key players in this communication, transmitting signals between the gut and the nervous system. Vagal and afferent innervation of these cells facilitates direct signaling to neuronal circuits, influencing pain, immune responses, and homeostasis. Disruptions in this interaction may contribute to gastrointestinal diseases, including inflammatory and functional bowel disorders. Stress and psychological factors can alter the composition and biomass of the enteric microbiota, affecting gut function and immune responses. The autonomic nervous system modulates gut functions such as motility, secretion, and immune responses, while stress-induced changes in gut permeability can allow bacterial antigens to enter the gut epithelium, triggering immune responses. The enteric microbiota can also influence the nervous system through signaling molecules, such as serotonin, which are secreted by enterochromaffin cells and can affect gut motility and secretion. The interaction between the gut microbiota and the nervous system is bidirectional, with the microbiota influencing gut function and the nervous system modulating the microbiota. This communication is mediated through various mechanisms, including direct signaling and paracrine interactions. The enteric microbiota can also influence the brain through signaling molecules, such as serotonin, which are involved in mood regulation and gut function. Stress can alter the balance of the gut microbiota, leading to changes in gut motility and secretion, which can contribute to gastrointestinal disorders. Clinical evidence suggests that modifications to the gut microbiota, such as through probiotics, can improve symptoms in conditions like IBS and IBD. The bidirectional signaling between the gut microbiota, the gut, and the brain has important implications for the treatment of gastrointestinal disorders. Understanding these interactions can lead to new therapeutic strategies for managing chronic intestinal disorders.